Teladoc Health, Inc. provided earnings guidance for the second quarter and full year of 2022. For the quarter, the company expects revenue in the range of $580 million to $600 million, Net loss per share in the range of $0.72 to $0.60, net loss of $116 million to $97 million.

For the year, the company expects revenue in the range of $2,400 million to $2,500 million, Net loss per share in the range of $43.50 to $43.00, net loss of $7,024 million to $6,944 million.